<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
</head>
<body>
<p>Dear All,</p>
<p>no conflict of interest.</p>
<p>Best,</p>
<p>Thomas<br>
</p>
<div class="moz-cite-prefix">Am 17/05/2024 um 15:59 schrieb
Terpsithea Ketegeni:<br>
</div>
<blockquote type="cite"
cite="mid:GV3P280MB0178433CA7BE03230C0CCE41E8EE2@GV3P280MB0178.SWEP280.PROD.OUTLOOK.COM">
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta name="Generator"
content="Microsoft Word 15 (filtered medium)">
<style>@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}@font-face
{font-family:Aptos;}p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
font-size:11.0pt;
font-family:"Aptos",sans-serif;
mso-fareast-language:EN-US;}a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#467886;
text-decoration:underline;}p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
font-size:11.0pt;
font-family:"Aptos",sans-serif;
mso-fareast-language:EN-US;}span.EmailStyle21
{mso-style-type:personal-reply;
font-family:"Aptos",sans-serif;
color:windowtext;}.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;
mso-ligatures:none;}div.WordSection1
{page:WordSection1;}ol
{margin-bottom:0cm;}ul
{margin-bottom:0cm;}</style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
<div class="WordSection1">
<p class="MsoNormal">Dear all,<o:p></o:p></p>
<p class="MsoNormal">We received a message from the EC PO
informing us that due to unforeseen reasons 2 experts declined
last minute from the Review Meeting. <o:p></o:p></p>
<p class="MsoNormal"
style="outline: 0px;font-variant-ligatures: normal;font-variant-caps: normal;font-variant-numeric: inherit;font-variant-east-asian: inherit;font-variant-alternates: inherit;font-variant-position: inherit;font-stretch: inherit;font-optical-sizing: inherit;font-kerning: inherit;font-feature-settings: inherit;font-variation-settings: inherit;orphans: 2;text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
<o:p> </o:p></p>
<p class="MsoNormal">Therefore, she would like us to urgently
check the potential conflict of interest for the following
experts and revert to her by Monday, 20/05/2024.
<o:p></o:p></p>
<p class="MsoNormal"
style="outline: 0px;font-variant-ligatures: normal;font-variant-caps: normal;font-variant-numeric: inherit;font-variant-east-asian: inherit;font-variant-alternates: inherit;font-variant-position: inherit;font-stretch: inherit;font-optical-sizing: inherit;font-kerning: inherit;font-feature-settings: inherit;font-variation-settings: inherit;orphans: 2;text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
1. Silvia Bolognin, University of Maastricht, NL<o:p></o:p></p>
<p class="MsoNormal"
style="outline: 0px;font-variant-ligatures: normal;font-variant-caps: normal;font-variant-numeric: inherit;font-variant-east-asian: inherit;font-variant-alternates: inherit;font-variant-position: inherit;font-stretch: inherit;font-optical-sizing: inherit;font-kerning: inherit;font-feature-settings: inherit;font-variation-settings: inherit;orphans: 2;text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
2. Maria Chiara Carrozza, Scuola Superiore Sant'Anna, IT<o:p></o:p></p>
<p class="MsoNormal"
style="outline: 0px;font-variant-ligatures: normal;font-variant-caps: normal;font-variant-numeric: inherit;font-variant-east-asian: inherit;font-variant-alternates: inherit;font-variant-position: inherit;font-stretch: inherit;font-optical-sizing: inherit;font-kerning: inherit;font-feature-settings: inherit;font-variation-settings: inherit;orphans: 2;text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
3. Cecilia Laschi, National University of Singapore, SG<o:p></o:p></p>
<p class="MsoNormal"
style="outline: 0px;font-variant-ligatures: normal;font-variant-caps: normal;font-variant-numeric: inherit;font-variant-east-asian: inherit;font-variant-alternates: inherit;font-variant-position: inherit;font-stretch: inherit;font-optical-sizing: inherit;font-kerning: inherit;font-feature-settings: inherit;font-variation-settings: inherit;orphans: 2;text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
4. Eduardo FERNANDEZ JOVER, University Miguel Hernández, ES<o:p></o:p></p>
<p class="MsoNormal"
style="outline: 0px;font-variant-ligatures: normal;font-variant-caps: normal;font-variant-numeric: inherit;font-variant-east-asian: inherit;font-variant-alternates: inherit;font-variant-position: inherit;font-stretch: inherit;font-optical-sizing: inherit;font-kerning: inherit;font-feature-settings: inherit;font-variation-settings: inherit;orphans: 2;text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
<o:p> </o:p></p>
<p class="MsoNormal">Kindly get back to Maria and myself in case
you have a Conflict of interest as soon as possible.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">BR,<o:p></o:p></p>
<p class="MsoNormal">Terpsi <o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Please see below the conflict of interest
rules. <br>
<br>
<o:p></o:p></p>
<p class="MsoNormal"
style="outline: 0px;font-variant-ligatures: normal;font-variant-caps: normal;font-variant-numeric: inherit;font-variant-east-asian: inherit;font-variant-alternates: inherit;font-variant-position: inherit;font-stretch: inherit;font-optical-sizing: inherit;font-kerning: inherit;font-feature-settings: inherit;font-variation-settings: inherit;orphans: 2;text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-thickness: initial;text-decoration-style: initial;text-decoration-color: initial;word-spacing:0px">
General guidelines to identifying CoI or appearances of CoI.<br>
1. Individuals who have jointly applied for funding within the
last three years or who are on the same active grants.<br>
2. If one of the individual's organization stands to benefit
directly or indirectly, or be disadvantaged as a direct result
of the monitoring of the project (i.e. an expert who is member
of an Advisory Board of the project, the institutional program
or an institution/company of one of the beneficiaries).<br>
3. Individuals with close family or personal relationship.<br>
4. Individuals who have collaborated and co-authored a
publication within the last 3 years.<br>
5. Individuals who have been in a mentor-mentee or
trainer-trainee within the last three years. <o:p></o:p></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<div>
<div
style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0cm 0cm 0cm">
<p class="MsoNormal"><b><span lang="EN-US"
style="font-family:"Calibri",sans-serif;mso-fareast-language:SV">From:</span></b><span
lang="EN-US"
style="font-family:"Calibri",sans-serif;mso-fareast-language:SV">
Terpsithea Ketegeni
<br>
<b>Sent:</b> den 18 april 2024 10:38<br>
<b>To:</b> <a class="moz-txt-link-abbreviated" href="mailto:all_biofine@lists.chalmers.se">all_biofine@lists.chalmers.se</a><br>
<b>Subject:</b> RE: BioFine - Date for the EC Review
meeting & rehearsal meeting <o:p>
</o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Dear all,<o:p></o:p></p>
<p class="MsoNormal"><span lang="EN-US">Please get back to me on
the following topics asap.
<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US">So far, I have only
heard from Maria and Stefano.<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoNormal"><span lang="EN-US">BR,<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US">Terpsi <o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"><o:p> </o:p></span></p>
<div>
<div
style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0cm 0cm 0cm">
<p class="MsoNormal"><b><span lang="EN-US"
style="font-family:"Calibri",sans-serif;mso-fareast-language:SV">From:</span></b><span
lang="EN-US"
style="font-family:"Calibri",sans-serif;mso-fareast-language:SV">
Terpsithea Ketegeni
<br>
<b>Sent:</b> den 17 april 2024 11:21<br>
<b>To:</b> <a
href="mailto:all_biofine@lists.chalmers.se"
moz-do-not-send="true" class="moz-txt-link-freetext">all_biofine@lists.chalmers.se</a><br>
<b>Subject:</b> BioFine - Date for the EC Review meeting
& rehearsal meeting <br>
<b>Importance:</b> High<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Dear all,<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<ol style="margin-top:0cm" start="1" type="1">
<li class="MsoListParagraph"
style="margin-left:0cm;mso-list:l1 level1 lfo3"><span
lang="EN-US">Maria and I just had a meeting with the EC PO
and we can confirm that the meeting will not take place on
the 07/05, but most possibly on the 14/05 and it will be a
full day – until 16.30. <o:p></o:p></span></li>
</ol>
<p class="MsoNormal"><span lang="EN-US"> We
would also like to explore the
<b><u>possibility of 22<sup>nd</sup> or 23<sup>rd</sup> of
May</u></b> as an alternative in case the external
experts are not available for our meeting.
<o:p></o:p></span></p>
<p class="MsoNormal"><span lang="EN-US"> <u>Therefore,
could you please inform us about your availability for
these two dates as soon as possible.
<o:p></o:p></u></span></p>
<p class="MsoNormal"><u><span lang="EN-US"><o:p><span
style="text-decoration:none"> </span></o:p></span></u></p>
<p class="MsoNormal"><u><span lang="EN-US"><o:p><span
style="text-decoration:none"> </span></o:p></span></u></p>
<ol style="margin-top:0cm" start="2" type="1">
<li class="MsoListParagraph"
style="margin-left:0cm;mso-list:l1 level1 lfo3"><span
lang="EN-US">Given that the EC review meeting will take
place in the middle of the May, we suggest that we
reschedule the mock-up rehearsal meeting from 24/05 to
either 02/05 or 03/05, 09:00-12:00. This will allow all
WPs to revisit and update the presentations.
<o:p></o:p></span></li>
</ol>
<p class="MsoListParagraph"><u><span lang="EN-US">Please inform
us if these time slots are not convenient for you.
<o:p></o:p></span></u></p>
<p class="MsoListParagraph"><span lang="EN-US"><o:p> </o:p></span></p>
<p class="MsoListParagraph"><span lang="EN-US">BR,<o:p></o:p></span></p>
<p class="MsoListParagraph"><span lang="EN-US">Terpsi <o:p></o:p></span></p>
</div>
<br>
<fieldset class="moz-mime-attachment-header"></fieldset>
</blockquote>
<pre class="moz-signature" cols="72">--
--
ACHTUNG: NEUE ADRESSE
+++++++++++++++++++++++++++++++++++++++++++++
Prof. Dr.-Ing. Thomas Stieglitz, Fellow IEEE
Spokesperson IMBIT // BrainLinks-BrainTools
Managing Director IMTEK
Professur für Biomedizinische Mikrotechnik
Institut für Mikrosystemtechnik (IMTEK)
Albert-Ludwigs-Universität Freiburg
IMBIT // Georges-Köhler-Allee 201
79110 Freiburg
Laboratory for Biomedical Microtechnology
Department of Microsystems Engineering - IMTEK
University of Freiburg
IMBIT // Georges-Koehler-Allee 201
79110 Freiburg, Germany
phone: +49 761 203 7471
fax: +49 761 203 7472
email: <a class="moz-txt-link-abbreviated" href="mailto:thomas.stieglitz@imtek.uni-freiburg.de">thomas.stieglitz@imtek.uni-freiburg.de</a>
url: <a class="moz-txt-link-freetext" href="http://www.imtek.de/bmt">http://www.imtek.de/bmt</a>
+++++++++++++++++++++++++++++++++++++++++++++</pre>
</body>
</html>